Drugmakers agree to participate in second round of price negotiations
All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...
Drug Store News28d
Axsome, Teva settle litigation over Auvelity
Axsome will grant Teva a license to sell its generic version of Auvelity beginning on or after March 31, 2039, if pediatric exclusivity is granted, or on or after Sept. 30, 2038, if no pediatric ...
Hosted on MSN5mon
Teva pays $450 million to settle kickback scheme charges
Oct. 10 (UPI) --Teva Pharmaceuticals, the largest generic drug manufacturer in the United States, has agreed to pay $450 million to resolve two claims that allege the company violated the Anti ...
Zacks Research Has Pessimistic Outlook of TEVA Q4 Earnings
Research analysts at Zacks Research reduced their Q4 2025 earnings estimates for Teva Pharmaceutical Industries in a research ...
Seeking Alpha29d
Teva and Alvotech get FDA review acceptance for its proposed biosimilar to Eylea
Alvotech (NASDAQ:ALVO) and Teva Pharmaceuticals (NYSE:TEVA) said on Tuesday that the U.S. FDA has accepted for review a Biologics License Application for a biosimilar targeting Regeneron’s (REGN ...